认知功能作为短期药物治疗反应的预测者在重大抑郁症中:心态化的调解效应
Seon Hee Hwang1,2, Myung Sun Kim2, Byung Joo Ham1,3
1Department of Psychiatry, Korea University Anam Hospital, Seoul, Republic of Korea.
Psychiatry investigation
|May 22, 2025
概括
患有较好的记忆回忆的重度抑郁症 (MDD) 患者在服用药物8周后表现出更好的功能. 精神化还积极预测了MDD治疗中的功能改善.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 认知心理学 认知心理学
背景情况:
- 大型抑郁症 (MDD) 与认知缺陷有关,包括受损的社会认知 (心态化).
- 这些认知缺陷可能会影响MDD患者的治疗结果.
- 了解认知,心态化和治疗反应之间的关系对于优化MDD治疗至关重要.
研究的目的:
- 在药物治疗8周后,研究认知功能对MDD患者治疗反应的影响.
- 确定心态化是否调解了MDD的认知功能和治疗反应之间的关系.
- 确定预测MDD功能改善的特定认知领域.
主要方法:
- 认知功能 (记忆,注意力,执行功能,处理速度) 和心态在28名MDD患者的基线被评估.
- 神经心理测试和自我报告尺度被用于测量.
- 治疗反应的评估是基于症状严重程度和整体功能改善的结果.
主要成果:
- 延迟回忆,一种对记忆的衡量,对功能性改善进行了负面预测,而心态化则对其进行了积极预测.
- 心态化调解了延迟回忆和数字跨度向后对功能改善的间接影响.
- 延迟回忆对功能改善的直接影响,即使在对开始时的年龄进行控制后,仍然显著.
结论:
- 较低的基线记忆 (延迟回忆) 可能预测MDD的短期药理治疗的更好的结果.
- 认知功能,特别是记忆,在MDD患者的功能恢复中起着重要作用.
- 精神化是影响治疗反应和MDD功能改善的重要因素.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
217
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
217
01:23Antidepressant Drugs: MAOIs and Other Agents
382
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
382
01:29The Influence of Cognition on Affect
2
Cognition plays a pivotal role in shaping emotional experiences, as demonstrated by Schachter and Singer’s two-factor theory of emotion. According to this model, emotion arises from a combination of physiological arousal and cognitive interpretation. The body’s physiological response to stimuli is ambiguous and only gains emotional significance through cognitive labeling. For instance, an increased heart rate and adrenaline surge while standing near an attractive person may be...
2
01:25Cognitive Therapy
467
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
467
01:28Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214